Service | Source | Final Application Due Date | Funding Available | Match Required |
---|---|---|---|---|
Health Care |
Federal
HHS |
02-24-2025 | $3.8 M | No Match Required |
93.394 -- Cancer Detection and Diagnosis Research
93.395 -- Cancer Treatment Research
The National Cancer Institute (NCI) intends to issue a U10 NCI National Clinical Trials Network (NCTN) � Canadian Collaborating Clinical Trials Network notice of funding opportunity (NOFO). The NCTN Canadian Collaborating Clinical Trials Network will be a full partner with the U.S. Network in the conduct of large-scale, multi-site clinical trials and help provide regulatory expertise/oversight for the conduct of NCTN trials in Canada. This. The primary goal of the NCTN is the conduct of multi-center, late-phase, clinical treatment trials (i.e., randomized phase 2 and phase 3 trials) and advanced imaging trials across a broad range of cancers, modalities, and diverse patient populations with relevance to the U.S. patient population as part of the NCI's overall clinical research program for adults, adolescents and young adults, and children with cancer. The NCTN also conducts umbrella/basket trials and rare tumor trials, when an extensive, national patient catchment area is required. This Notice of Intent to Publish is being provided to allow sufficient time for the applicant to develop a strong application. The NOFO is expected to be published in Fall 2024 with only one expected application due date in late February 2025. �
How would you rate your overall experience on our website?
How easy is it to find the information you need?
How do you rate the look & feel of our website?
How could we improve our website?